Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pplabaj
    Junior Member
    • Mar 2024
    • 7

    #1

    The Anti-Microbial Resistance Prediction Challenge - CAMDA@ISMB 15-16 July, 2024, Montreal, Canada

    Try your best & take the next CAMDA challenge: Develop models for predicting antimicrobial resistance to 2 drugs in 8 different bacterial pathogens from the WHO’s Priority Pathogen List!

    Critical Assessment of Massive Data Analysis (CAMDA) runs in collaboration with ISMB, which joins up with ECCB every other year. CAMDA is an established full conference track at ISMB, representing one of its Communities of Special Interests (COSIs). This gives you wide exposure and further opportunities for interaction with colleagues without separate registration fees. You just register with one of multiple options at ISMB, specifying CAMDA as your interest.

    CAMDA focuses on one of the grand challenges of our time, the intelligent exploitation of Big Data in the life sciences. In the post-genomic era, an effective scientific interpretation of large datasets is key to new medical and biological insights from novel high throughput assays and the increasing size of biomedical studies.
    CAMDA puts a spotlight on the successful analysis and integration of the massive data sets now prevalent in the life sciences.
    ​
    This year, recognizing the recent events, the scientific committee of CAMDA has set the following​ data contest challenge:​
    • The Anti-Microbial Resistance Prediction Challenge features clinical isolates sequences. Predict resistance genes/markers and identify resistant bacteria!
    • The Gut Microbiome based Health Index Challenge features hundreds of WMS based taxonomic and functional profiles of healthy and unhealthy individuals. Take advantage of the Theater of Activity concept and compete already existing taxonomy based metrics!
    • The Synthetic Clinical Health Records Challenge provides a rich set of highly realistic Electronic Health Records (EHR) tracing the diagnosis trajectories of diabetic patients, created with dual-adversarial auto-encoders trained on data from 1.2 million real patients in the Population Health Database of the Andalusian Ministry of Health. Predict relevant diabetes endpoints like blindness or cardiopathy from past diagnosis trajectories!

    CAMDA encourages an open contest, where all analyses of the contest data sets are of interest, not limited to the questions suggested here. There is an online forum for the free discussion of the contest data sets and their analysis, in which you are encouraged to participate.

    We look forward to a lively contest!

    Read more at camda.info
    ​​
    On behalf of CAMDA organizing committee,
    Paweł Łabaj​​

    Click image for larger version

Name:	Camda Logo_2024_round#5fa660_wYear_450.jpg
Views:	206
Size:	28.8 KB
ID:	325589

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
29 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...